These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31060750)

  • 1. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.
    Ettel M; Zhao L; Schechter S; Shi J
    Pathology; 2019 Jun; 51(4):392-398. PubMed ID: 31060750
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
    Fukuda A
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.
    von Figura G; Fukuda A; Roy N; Liku ME; Morris Iv JP; Kim GE; Russ HA; Firpo MA; Mulvihill SJ; Dawson DW; Ferrer J; Mueller WF; Busch A; Hertel KJ; Hebrok M
    Nat Cell Biol; 2014 Mar; 16(3):255-67. PubMed ID: 24561622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
    Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation.
    Shipman GA; Padilla R; Horth C; Hu B; Bareke E; Vitorino FN; Gongora JM; Garcia BA; Lu C; Majewski J
    Genome Biol; 2024 Oct; 25(1):263. PubMed ID: 39390582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pdx1 expression in pancreatic precursor lesions and neoplasms.
    Park JY; Hong SM; Klimstra DS; Goggins MG; Maitra A; Hruban RH
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):444-9. PubMed ID: 21297446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
    Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
    Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
    Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli2 protein expression level is a feasible marker of ligand-dependent hedgehog activation in pancreatic neoplasms.
    Sugiyama Y; Sasajima J; Mizukami Y; Koizumi K; Kawamoto T; Ono Y; Karasaki H; Tanabe H; Fujiya M; Kohgo Y
    Pol J Pathol; 2016 Jun; 67(2):136-44. PubMed ID: 27543868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
    Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
    Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
    Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
    Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression in pancreatic intraepithelial neoplasia (PanIN): steady increase along the developmental stages of pancreatic ductal adenocarcinoma.
    Bhanot U; Heydrich R; Möller P; Hasel C
    Am J Surg Pathol; 2006 Jun; 30(6):754-9. PubMed ID: 16723855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
    Fujikura K; Alruwaii ZI; Haffner MC; Trujillo MA; Roberts NJ; Hong SM; Macgregor-Das A; Goggins MG; Roy S; Meeker AK; Ding D; Wright M; He J; Hruban RH; Wood LD
    J Pathol; 2021 Jul; 254(3):279-288. PubMed ID: 33870509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Niu N; Lu P; Yang Y; He R; Zhang L; Shi J; Wu J; Yang M; Zhang ZG; Wang LW; Gao WQ; Habtezion A; Xiao GG; Sun Y; Li L; Xue J
    Gut; 2020 Apr; 69(4):715-726. PubMed ID: 31300513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
    Lucio-Eterovic AK; Singh MM; Gardner JE; Veerappan CS; Rice JC; Carpenter PB
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16952-7. PubMed ID: 20837538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
    Ohya A; Yamanoi K; Shimojo H; Fujii C; Nakayama J
    Cancer Sci; 2017 Sep; 108(9):1897-1902. PubMed ID: 28685935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas.
    Mito K; Saito M; Morita K; Maetani I; Sata N; Mieno M; Fukushima N
    Pancreatology; 2018 Jun; 18(4):407-412. PubMed ID: 29650332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.